Skip to main content

Table 1 Pain control protocol for total joint arthroplasty

From: Risk factors for liposomal bupivacaine resistance after total hip or knee arthroplasties: a retrospective observational cohort in 237 patients

Preoperative

Postoperative

 

Inpatient

On discharge

Celecoxib PO - 200 mg

Pregabalin PO - 50 mg (<65yo), 25 mg (>65yo)

Acetaminophen IV – 1000 mg once

Celecoxib PO - 200 mg daily

Pregabalin PO - 50 mg BID (<65yo)

MS Contin PO – 15 mg BID (<65yo)

Acetaminophen IV – 1000 mg q8h (1st 24 h)

Acetaminophen PO – 650 mg q6h (> 24 h)

Oxycodone PO – 5 mg q4h PRN pain 1–3

Oxycodone PO – 10 mg q4h PRN pain 4–6

Morphine IV – 2 mg q4h PRN pain 7–10

Patient-controlled analgesiaa

Percocet PO - 5/325 mg q4-6h PRN

Celecoxib PO - 200 mg daily (2 weeks)

Pregabalin PO - 50 mg BID (<65yo) (2 weeks)

MS Contin PO – 15 mg BID (<65yo) (2 weeks)

  1. apatient-controlled anesthesia was provided at the discretion of the anesthesia department and was not offered to all patients